International
The Morning Science

What science found today

‹
 

Research

Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation

PLOS ·

The Brief

  • A target trial emulation study in Brazil examined loss to follow-up during tuberculosis treatment and 5-year mortality.
  • The study was published in PLOS Medicine on 2026-11-18 by researchers including Evelyn Lepka de Lima and Jason R. Andrews.
  • The headline links loss to follow-up during TB treatment to mortality, based on the study's 5-year outcomes.

Why it matters

Patients who drop out of tuberculosis treatment may face higher risk of death, so tracking and retaining patients in care matters for TB control programmes. The study's target trial emulation design uses observational data to estimate effects that would otherwise need a randomised trial.

Who’s affected

  • tuberculosis clinicians and public health researchers
  • health policy makers running TB programmes in Brazil

by Evelyn Lepka de Lima, Ana Angélica Lindoso, Giovanna Mariah Orlandi, Suely Fukasava, Catia Martinez, Julio Croda, C. Robert Horsburgh Jr, Otavio Ranzani, Meredith B. Brooks, Jason R. Andrews Background Loss to follow-up (LTFU) during tuberculosis treatment is a major…

Timeline

  1. Study published in PLOS Medicine

  2. PLOS Medicine

    Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation

How do you feel about this?

0 Comments

    Loss to follow-up during tuberculosis treatment and 5-year mortality in Brazil: A target trial emulation – The Morning Science